Live feed
Filing
SC 13G
SC 13G0001387131-22-001971·Acumen Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Acumen Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00509G209
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 40,106,783
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-22-001971
- Form type
- SC 13G
- Filer
- Acumen Pharmaceuticals, Inc.
- CIK
- CIK 1576885
- Filed
- Feb 15, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership